ArticleDiscover oncology2025

Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVAD.

Jing Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.